Nigrosphaerin A, a new isochromene derivative (1), was isolated from the endophytic fungus Nigrospora sphaerica and chemically identified as 3- 
Introduction
Endophytic fungi are prospective producers of an abundant source of bioactive chemically novel compounds with potential for exploitation in a wide variety of medical areas (Tenguria et al., 2011) . Fungi belonging to the genus Nigrospora have been a rich source of bioactive secondary metabolites, such as nigrosporolides which found to have plant growth-inhibiting activity (Kim et al., 2001) , phomalactones with good anti plant pathogenic fungi effect (Kim et al., 2001) , phytotoxic antibacterial nigrosporins (Tanaka et al., 1997) , phytotoxic lactones (Fukushima et al., 1998) , epoxydons and pyrones (Trisuwan et al., 2008) .
The fungus Nigrospora sphaerica has been reported as an endophyte in several plants and marine organisms (Zhang et al., 2009) . N. sphaerica has been found to be a source of biologically active secondary metabolites, including diterpenes (Turner and Aldridge, 1983) , diketopiperazines (Cutler et al., 1991) , lactones (Kim et al., 2001 ) and nigrosporolides (Zhang et al., 2009 ).
Chemical and biological investigation for the endophytic fungus N. sphaerica (Fig. 1) , led to the isolation of Nigrosphaerin A, a new isochromene derivative (1), along with nineteen known compounds (2-20). The antileukemic, antileishmanial, antifungal and antibacterial activities of the isolated compounds were studied.
Results and discussion
Compound 1 ( Fig. 2A) of unsaturation. The IR spectrum showed that 1 contained hydroxyl (ν max 3405 cm −1 ), and carbonyl (ν max 1648 cm −1 ) functional groups. The UV spectrum showed absorption bands at λ max 255, 290 (sh) and 365.0 nm.
The 1 H NMR spectroscopic data of 1 displayed signals at δ H 7.59 (1H, d, J = 2.0 Hz, H-2′), δ H 7.45 (1H, dd, J = 8.4, 2.0 Hz, H-6′) and δ 6.86 H (1H, d, J = 8.4, H-5′) indicating a 1,3,4-trisubstituted benzene ring. These protons were found to be correlated to δ C 114.8, δ C 119.7 and δ C 115.8 in the HMQC spectrum, respectively. Two meta coupled aromatic protons resonating at δ H 6.64(1H, d, J = 1.6 Hz, H-5) and δ H 6.75(1H, d, J = 1.6 Hz, H-7) were correlated to δ C 97.5 and to δ C 103.4 in the HMQC spectrum, respectively. The hydroxyl proton (C-8) found to be resonating at δ H 13.48 due to intermolecular hydrogen bonding with the carbonyl group (C-1). The 13 C NMR, DEPT and HMQC spectroscopic data of 1 displayed 21 signals, including one methylene, ten methine and ten quaternary carbons. The carbon resonating at δ C 171.8 ppm is characteristic for carbonyl group (C-1). The 13 C, HMQC and HMBC NMR data further established four phenolic hydroxyl groups at C-4 (δ C 157.4), C-8 (δ C 163.3), C-3′ (δ C 145.3) and C-4′ (δ C 147.5). Six carbons for sugar were found to be resonating at δ C 103.9 (C-1″), δ C 73.8 (C-2″), δ C 77.6 (C-3″), δ C 69.8 (C-4″), δ C 75.8 (C-5″) and δ C 60.8 (C-6″). Anomeric proton at δ H 4.77 found to be correlated to C-1″ at δ C 103.9 in the HMQC spectrum and to δ C 158.5 in the HMBC spectrum, indicating that the sugar is attached to C-6. The large coupling constant of the anomeric proton J = 7.2 Hz indicated the β-configuration of the sugar (Avilov et al., 2003; Gao et al., 2008) . The following correlations have been found in the HMBC spectrum ( Fig. 2B ): H-7 (δ H 6.75) to C-5 (δ C 97.5) and C-9 (δ C 106.1), from H-5 (δ H 6.64) to C-4 (δ C 157.4) and C-9 (δ C 106.1), from H-2′ (δ H 7.59) to C-3 (δ C 143.6), C-4′ (δ C 147.5) and C-6′ (δ C 119.7), from H-5′ (δ H 6.86) to C-1′ (δ C 122.2) and C-3′ (δ C 145.3) and from H-6′ (δ H 7.45) to C-2′ (δ C 114.8) and C-4′ (δ C 147.5). The hydrolysis of 1 with 0.5 N HCl yielded 3-(3,4-dihydroxyphenyl)-4,6,8-trihydroxy-1H-isochromen-1-one and glucose which was identified by co-chromatography with standard sugars using TLC. Based on the above evidences, the structure of 1 was established as 3-(3,4-dihydroxyphenyl)-4,6,8-trihydroxy-1H-isochromen-1-one-6-O-β-D-glucopyranoside.
Fifteen compounds (2-16, Fig. 3 ) have been isolated and were chemically identified using 1D NMR ( 1 H, 13 C, DEPT135) and 2D NMR (COSY, HMQC, HMBC) as well as HR-ESI-MS and found to be ergosta-6,22-diene-3β,5α,8α-triol (2) (Cateni et al., 2007) , ergosta-7,22-diene-3β-ol (3) (Gong et al., 2010), ergosta-4,6,8(14) ,22-tetraene-3β-ol (4) (Pang and Sterner, 1993), ergosta-4,6,8(14) ,22-tetraene-3one (5) (Lee et al., 2005) , ergosta-5(6),7,22-triene-3β-ol (6) (Li et al., 2007) , ergosta-7,9(14),22-triene-3β-ol (7) (Li et al., 2008a) , ergosta-7,22-epidioxy-3β-ol (8) (Cateni et al., 2007) , 4-(hydroxymethyl)-3,5-dimethyl dihydrofuran-2(3H)-one (9) (Rukachaisirikul et al., 2009 ), 3-(1-hydroxyethyl)-4-methyl dihydrofuran-2(3H)-one (10) (Choi et al., 2008) , uridine (11) (Mantsch and Smith, 1973) , adenosine (12) (Liu et al., 2011) , 3-benzylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione (13) (Fdhila et al., 2003) , 3-methylhexahydro pyrrolo[1,2-a]pyrazine-1,4-dione (14) (Hendea et al., 2006) and methyl 4-hydroxybenzoate (15) (Li et al., 2008b) , 4-(2-hydroxyethyl)phenol (16) (Li et al., 2012) . Four fatty acids (17-20) have been also isolated and chemically identified as stearic acid (17), oleic acid (18), palmitic acid (19), and myristic acid (20) using 1 H NMR and GC/MS after methylation.
Compounds 5, 7, 9 and 10 showed good antileukemic activity (Table 1 and 
Experimental

General
NMR spectra were recorded on a Bruker Avance DRX-500 instrument at 500 ( 1 H) and 125 MHz ( 13 C), and a Varian Mercury 400 MHz spectrometer at 400 ( 1 H) and 100 MHz ( 13 C). The HR-ESI-MS spectra were measured using a Bruker Bioapex-FTMS with electrospray ionization (ESI). The GC-MS was interfaced to a HP 5973 quadrupole mass selective detector. The injector temperature was 250 °C, and 1 μL injections were performed in the split (1:10) mode using helium as carrier gas. Column chromatographic separation was performed on silica gel 60 (0.04-0.063 mm) and sephadex LH-20 (0.25-0.1 mm, Merck). TLC was performed on precoated TLC plates with silica gel 60 F254 (0.2 mm, Merck). Semi preparative HPLC (Waters Delta Prep 4000) was performed using Luna ® RP-18 (250,10 mm × 5 μm; flow rate 5 μL/min).
Fungal material
The fungus N. sphaerica was isolated from surface sterilized fresh leaves of an apparently healthy vinca rosea (Apocynaceae) collected in March 2010 in Cairo, Egypt. The leaves were rinsed with water and followed by surface sterilization in 70% EtOH for 1 min, rinsed with sterilized water, then cut into small pieces (2 cm in length and width) and deposited in on a petri dish containing PDA medium (200 g potato, 20 g glucose, and 15 g agar in 1 L distilled water, supplemented with 100 mg/L chloramphenicol) and cultivated at 28 °C for 3 days. The hypha tips were observed and transferred to new PDA plates and subcultured until pure culture was obtained. The fungus was identified by the regional center for mycology and biotechnology, Cairo, Egypt. Identification was based on The Data Base Identification Program of the Regional Center for Mycology and Biotechnology (RCMB) for fungi, using an Image Analysis System and on current universal keys (Fisher and Cook, 1998; Hoog et al., 2000) . After purification the fungus was grown on PDA at 28 °C for 5 days. Ten pieces (0.5 × 0.5 cm 2 ) of mycelial agar plugs were inoculated into ten 1000 mL Erlenmeyer flasks containing sterilized (100 g Asian rice and 100 ml distilled water) at room temperature for 40 days.
Extraction and Isolation
The fungus was extracted by adding 2 L EtOAc to each flask and homogenized. The homogenized suspensions were collected, filtrated, concentrated under vacuum and partitioned with distilled water. Ethyl acetate portion was evaporated to dryness and fractionated using hexane and 90% MeOH to afford hexane fraction (7.6 g) and MeOH fraction (8.0 g). Water portion was fractionated against n-butanol to afford water fraction (36 g) and butanol fraction (7 g). N. sphaerica MeOH fraction (8 g) was subjected to Si gel VLC eluted with hexane, EtOAc and finally MeOH. Six fractions were collected (500 mL each). Fractions 2-3 (410.9 mg) were chromatographed on sephadex LH-20 using eluent MeOH:CHCl 3 (5:5) to yield nine subfractions. Subfraction 2 was chromatographed with Si-SPE column eluted with CHCl 3 , MeOH in a matter of increasing polarity to afford compound 2 (3 mg), compound 4 (5 mg) and compound 5 (4 mg). Subfraction 3 was chromatographed on Si-SPE column eluted with CHCl 3 , MeOH to give compounds 6 (12.6 mg) and 8 (1.3 mg). Subfraction 4 was chromatographed on sephadex LH-20 using eluent MeOH:CHCl 3 (5:5) to afford compound 7 (2.4 mg) and compound 3 (3.9 mg). Subfractions 5-6 was chromatographed on Si gel eluted with CHCl 3 , MeOH in a matter of increasing polarity to afford compounds 9 (5.8 mg) and compound 10 (2.7 mg).
The butanol fraction (7.0 mg) was subjected to Si gel VLC gradient eluted with CHCl 3 / MeOH and finally MeOH. Eight fractions were collected (500 mL each). Fraction 2 (17.8 mg) was chromatographed on sephadex LH-20 eluting with MeOH/H 2 O, followed by purification with semi-preparative HPLC eluted with 75% MeOH/H 2 O to give compound 1 (6.3 mg). Fractions 3-4 (702.9 mg) were chromatographed on sephadex LH-20 eluting with MeOH to yield 5 subfractions. Subfraction 2 was chromatographed on RP-Si-SPE (C18) column using eluent H 2 O:MeOH (6:4) to give compounds 11 (6.7 mg) and 15 (7.3 mg). Subfraction 3 was chromatographed on sephadex LH-20 eluting with MeOH to give compound 12 (15.9 mg). Subfraction 4 was chromatographed with semi-preparative HPLC with linear gradient elution 20-85% aqueous methanol to obtain compounds 13 (7.8 mg), 14 (4.3 mg) and 16 (1.4 mg). 
3-(
Acid hydrolysis of compound 1
2 mg of compound 1 was refluxed with HCl (0.5 N, 2 mL) for 2 h. The hydrolyzed product was extracted with CH 2 Cl 2 /H 2 O. The sugar was extracted from the aqueous layer using pyridine (1 mL). The sugar was identified as D-glucose by co-chromatography with authentic samples of different sugars using silica gel TLC using solvent system EtOAc/MeOH/ HOAc/H 2 O (11:2:2:2) followed by spraying with anisaldehyde/H 2 SO 4 and heating at 100 °C.
Antileukemic assay
Human acute leukemia HL60 cells and human chronic leukemia 562 cells were purchased from American Type Culture Collection, Rockville MD, USA. Both cell lines were grown in suspension culture at 37 °C in RPMI-1640 medium supplemented with 10% non-dialysed fetal bovine serum (FBS), 2 mM L-glutamine, 100 units/mL of penicillin and 10 μg/mL of streptomycin. For the cell growth inhibition assay, HL60 and K562 cells were set up at 1 × 10 5 cells/well in Costar 24-well plates. Cells were allowed to grow undisturbed for 24 h before addition of "compounds". After 48 h incubation with drugs at 37 °C, viable cell counts were made by using the trypan blue exclusion method to assess cell viability (Roper and Drewinko, 1976) . The concentration-dependent effects of compounds 5, 7, 9 and 10 on the growths of acute leukemia HL60 (A) and chronic leukemia K562 (B) cells. Cells were treated with compounds for 48 h and then cell numbers were determined by the trypan blue exclusion test. Results shown are mean ± SD (bars) of triplicate experiments. 
